EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinie

Antithrombotic therapy in patients with chronic coronary syndrome: a focus on the 2024 European Society of Cardiology guidelines

Antonio Landi, Marco Valgimigli iD

European Heart Journal: Acute Cardiovascular Care · 2025

DOI: 10.1093/ehjacc/zuae134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2025. Verfasst von Antonio Landi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Via Tesserete, 48, 6900 Lugano, Switzerland. Hauptthemen laut MEDLINE: Fibrinolytic Agents, Societies, Medical, Percutaneous Coronary Intervention, Cardiology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antithrombotic therapy represents the mainstay of the pharmacological treatment in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI). The optimal choice, combination, and duration of antithrombotic therapy represent still a clinical conundrum requiring a critical assessment of patient comorbidities, clinical presentation, and PCI features. The 2024 European Society of Cardiology (ESC) guidelines for the management of patients with CCS have been recently published encompassing new and revised recommendations on antithrombotic therapy. The scope of this manuscript is to provide a focus on the key recommendations on antithrombotic therapy of the 2024 ESC guidelines. Furthermore, we will provide an overview of differences and similarities between the latest ESC recommendations and statements on oral antithrombotic regimens in CCS patients from a recent European expert consensus document.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrinolytic AgentsSocieties, MedicalPercutaneous Coronary InterventionCardiologyPractice Guidelines as TopicHumansEuropeChronic Disease

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Via Tesserete, 48, 6900 Lugano, Switzerland.
  • Faculty of Biomedical Sciences, University of Italian Switzerland, via Giuseppe Buffi 13, 6900 Lugano, Switzerland.
  • University of Bern, Freiburgstrasse 20, 3010 Bern, Switzerland.

ORCID-Profile: Marco Valgimigli

Zitieren

APA

Landi, A., & Valgimigli, M. (2025). Antithrombotic therapy in patients with chronic coronary syndrome: a focus on the 2024 European Society of Cardiology guidelines. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuae134

Vancouver

Landi A, Valgimigli M. Antithrombotic therapy in patients with chronic coronary syndrome: a focus on the 2024 European Society of Cardiology guidelines. European Heart Journal: Acute Cardiovascular Care. 2025. doi:10.1093/ehjacc/zuae134

BibTeX
@article{Landi2025,
  author = {Landi, Antonio and Valgimigli, Marco},
  title = {Antithrombotic therapy in patients with chronic coronary syndrome: a focus on the 2024 European Society of Cardiology guidelines},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2025},
  doi = {10.1093/ehjacc/zuae134}
}
Kostenlos starten →